Compound: Mitoxantrone

Drug Target: TOP2

Drug Target pathway: DNA replication

DatasetDatasets
GDSC1: Screened in 96 or 384-well plates with Cyto60 or Resazurin endpoint
GDSC2 (recommended where available): 1536-well plates with CellTiterGlo endpoint
See documentation for more information and screening differences


Associations from all tissue specific and pan-cancer ANOVA analyses overlaid. Hover the pointer over each circle to reveal the context-specific details of an association.

Retrieving drug sensitivity data...

Contact us | Cookies policy | Terms & Conditions. This site is hosted by the Wellcome Sanger Institute.